Objective: To provide an overview ofthe palliative care literature salient to the psychiatric aspect ofend-of-life care.
P atients nearing death face enormous, "never-beforeencountered" psychological challenges. The psychiatrist who works in this setting must be sensitive to these issues and prepared to explore them in depth. Recent advances in palliative medicine have established that dying patients experience various symptoms as death draws nearer (1) (2) (3) . As it does so, the distinction between somatic distress and psychological or spiritual disquietude becomes less clear. Psychiatrists are in a particularly advantageous position to assist dying patients, their families, and care providers in navigating this challenging terrain. Knowledge ofphysical medicine combines with a broad range of psychiatric expertise to create a rich set of skills, which can inform our understanding of palliative medicine and the multiple facets of caring for the dying.
Palliative Care and the Psychiatrist
Gerasim was the only one who understood him. It was a comfort when Gerasim sat with him sometimes the whole night through.... Gerasim was the only one who did not lie; everything he did showed that he alone understood what was happening, and saw no need to conceal it ... and so the relationship was a comfort to him.
-Leo Tolstoy, The Death ofIvan Ifyich Ivan Ilyich's pantry boy Gerasim seems able to maintain his composure and to offer comfort, even when death is very near. For the psychiatrist working in palliative care, both abilities are requisite. Health care providers all too often approach the dying with a sense oftherapeutic nihilism-that is, expecting and accepting their patients' suffering. To work among the dying, one must have some basic understanding of the palliative care philosophy and embrace the challenge of bringing comfort to them and improving their quality oflife.
To explicate the role of the psychiatrist in end-of-life care, it is helpful to begin by defining palliative care and more specifically "a good death." The tennpalliate-meaning "to reduce the violence of' or "to moderate the intensity of' a disease process-comes from the Latin palliare, which means "to shield or protect." Palliative care thus refers to the process of protecting or shielding the patient from the violence ofdisease at the end oflife (4) . The Canadian Palliative Care Association defines palliative care as "a combination of active and compassionate therapies intended to comfort and support individuals and families who are living with or dying from a progressive, life-threatening illness, or who are bereaved" (5) . According to the World Health Organization, "a good death" is one "free from avoidable distress and suffering for patient, family, and caregivers, is generally in accord with patient's and family's wishes, and reasonably consistent with clinical, cultural, and ethical standards" (6) . Dr Avery Weisman-a psychiatrist who did much early work in the area of thanatology-proposed some helpful goals for an "ideal" or "appropriate" death (7) . These include the following: graduation, marriage, or birth ofa child for a sense ofcontinuity into the future.
Bearing these in mind, a psychiatrist's role in attending to dying patients begins to emerge, a role that is multifaceted and covers an assortment of tasks requiring various skills. These tasks include the following:
1. Understanding and being able to explore with patients the multitude of psychological issues that frequently arise in the context of life-threatening conditions.
2. Being able to broach with families the issues and concerns that commonly present themselves in palliative care.
3.
Having an appreciation for the psychological issues and challenges faced by health care providers in attending to the needs of dying patients.
4.
Diagnosing and treating comorbid psychiatric disorders in patients with advanced and terminal medical conditions.
Frequent Psychological Issues and Life-Threatening Conditions
But when the lights are out, the darkness swims over us and talk between bed and bed is extinguished. Each ofus live in our own night, a drugged semi-sleep in which we darkly swim, sometimes floating up to the surface where the voices are... I can't sleep. I'm blurred, but the pain won't let me sleep.
-Margaret Laurence, The Stone Angel
As Margaret Laurence so poignantly captured in her characterization ofHagar-an elderly woman nearing the end ofher life-the challenges facing those who are approaching death are considerable and freely cross boundaries between physical, psychological, and spiritual discomfort. Perhaps more than other psychiatric encounters, respect for each individual's defensive style must guide this work, bearing in mind that dying patients frequently manifest varying levels of denial as part oftheir adaptation process (8) (9) (10) (11) . However, various concerns that are frequently encountered by patients nearing death should be borne in mind. Singer and others asked 126 patients with advanced illness to identify and describe elements of quality end-of-life care (12) . Participants identified 5 domains of quality end-of-life care, including receiving adequate pain and symptom management, avoiding inappropriate prolongation ofdying, achieving a sense ofcontrol, relieving the physical and emotional burden that their dying would impose on loved ones, and strengthening relationships with loved ones. These issues again point the way to an expanded role for the psychiatrist in palliative medicine.
Holland and others have described typical concerns of patients who face a life-threatening or terminal prognosis (13) . These concerns are frequently encountered in the palliative care setting and often arise when offering supportive assistance to dying patients.
Patients frequently convey various concerns about death and the manner in which they will die. They often imagine that their suffering will be overwhelming and that in the face of such suffering, their health care team will be rendered helpless. Exploring the specifics of these concerns and providing explicit information about symptom management can provide patients with tremendous comfort and relief. Occasionally, an association to a prior loss or the experience of witnessing a loved one's death may heighten this concern. To the extent that the patient feels comfortable in doing so, detailed exploration of these unconscious associations mayassist the patient.
Patients frequently fear progressive disability and the relinquishment ofpreviously held roles that results from their illness. Eric Cassel has suggested that suffering can be understood in terms ofthe extent to which one's sense of personhood is threatened or undermined (14) . When illness assaults the integrity of functions, roles, or attributes seen as "personally defining" or "central to one's being," suffering is commensurate. Psychiatrists can playa role in facilitating the appropriate grief work and can often assist patients who search for a continued sense of purpose and meaning in the face of imminent death. While one's approach must often be eclectic, techniques such as existential psychotherapy, reviewing "life narratives," interpersonal psychotherapy, crisis intervention, and supportive psychotherapy can help promote this meaningful work (15) (16) (17) . These approaches can helppatients to integrate the present illness into a continuum of life experiences and, for some, to explore issues of separation, loss, and the unknown that lies ahead.
Patients often fear disfigurement and the profound bodily changes that are associated with advanced illness. This is especially problematic for patients with head and neck, breast, and genitourinary cancers and those requiring ostomies (18). Psychotherapeutic interventions as described above can help some patients establish a bond with a therapist that will decrease their sense of isolation and enhance their continued sense of worth, while integrating the present illness into a continuum of life experiences.
Fear of losing independence and control are common concerns for the terminally ill. The loss of functional independence and the need to rely on others can often be a source of painful uneasiness and angst. In a recent study of patients with amyotrophic lateral sclerosis (ALS) by Ganzini and others, loss of independence and fear of losing control were highly associated with an interest in physician-assisted suicide (19) . It would thus appear that loss of autonomy and increasing dependency often lie at the heart of a dying patient's loss of the will to live. This speaks to the importance of designing palliative care interventions that heighten patient autonomy, allow individual decision-making, and respect unique needs, wishes, and priorities.
Patients frequently fear a loss of personal desirability and subsequent abandonment. They sometimes worry that their illness will become so burdensome and reprehensible, that everyone will be driven away. As such, one of the mainstays ofpalliative care intervention is the ongoing explicit commitment to remaining involved with patients and their families, no matter what the future course of illness. Psychiatric involvement can help accomplish this task by establishing a patient-therapist bond that helps the patient face death within a reliable unwavering network of support.
Family Issues in the Context of Palliative Care
Once he had told her something that she could not imagine: that amputees suffer pains, cramps, itches, in the leg that is no longer there. That is how she felt without him, feeling his presence where he no longer was.
-Gabriel Garcia Marquez, Lovein the Timeof Cholera
There is good evidence that dealing with a seriously ill patient places enormous demands on the rest of the family (20) (21) (22) . Studies ofcancer patients indicate that approximately 70% of primary family caregivers are spouses and about 20% are children, with daughters and daughters-in-law being most predominant; the remainder consists of friends or more distant relatives (23, 24) . The disruption in relationships created by the strain ofproviding care to a loved one can often lead to the patient's admission to hospital (25) . In a review of the research on the impact of cancer on a family, Lewis identified various separate issues concerning family members (26) . These included emotional strain, physical demands, uncertainty, fear ofthe patient dying, altered roles and lifestyles, finances, ways to comfort the patient, perceived inadequacies of services, existential concern, changes in the sexual relationship with the patient, and nonconvergent needs among household members. Hample identified 8 needs of family members of dying persons. These included: 1) to be with the dying person; 2) to be helpful to the dying person; 3) to receive assurance of the dying person's comfort; 4) to be informed of the dying person's condition; 5) to be informed of impending death; 6) to vent emotions; 7) to receive comfort and support from the family; and 8) to receive acceptance, support, and comfort from health care professionals (27) .
Patients and family members should be encouraged to use this period to reconcile differences, extend important final communications and reaffirm feelings and wishes. It is a vitally important time that can often set the tone for the subsequent bereavement (28) . Anticipatory bereavement is a common experience, which allows patients, loved ones, and health care providers the opportunity to prepare mentally for the impending death. Hays and others found that premorbid psychological symptoms in the weeks and months prior to the death were not reliably distinguishable from the earliest and most intense experiences of postmortem grief (29) . They reported nonsignificant differences in mean depression scores and hopelessness-helplessness scores between those not yet bereaved, those already bereaved, and spouses ofcritically ill patients who survived.
Depressive symptoms can occur at any point during the bereavement course, which raises the question, when do these symptoms constitute a disorder requiring treatment? The rates ofmajor depression among bereaved individuals peak at approximately 1 month postmortem, reaching nearly 50%, then decline at 2 months to 27% to 30%, and continue to drop to 16% at 1 year, after which they stabilize at this level for up to 2 years (30) . Depression in the context of bereavement does not appear to differ from major depression in the community with respect to age of onset, degree of dysfunction, visits to doctors, or the use of medication (31) . Nevertheless, Zizook and Schuchter found that 83% of bereaved spouses who met criteria for major depression received no antidepressant medications (32) . Thus, a highly disabling and potentially life-threatening illness is not being diagnosed and treated, further contributing to the burden of suffering of many of the bereaved.
Valid and reliable instruments are beginning to emerge to help track and study family needs and satisfaction with advanced cancer care (33) (34) (35) . Empirically based research will enhance our understanding of families and the way in which they adjust to the dying ofa loved one. For example, Kristjanson and others recently reported that family members of patients who had been diagnosed for longer than 2 years had significantly more positive perceptions ofpalliative care than did family members of patients diagnosed for less than 2 years (36) . In addition, older family members reported better family functioning than did younger family members, and spouses reported less discrepancy between care expectations and perceptions than did other relatives. Other investigators are exploring the reliability of family-bereavement outcome predictors (37, 38) . Research ofthis nature creates the exciting possibility that at-risk families may be identifiable and could be treated preventively to reduce morbidity. For many, palliative medicine challenges the very notion of what it is to be a health care provider. Much of contemporary medicine has focused on providing curative, life-prolonging interventions. When these measures are no longer viable, as we are coming to recognize in the late 20th century, medicine frequently sees itself as having little to offer (39) . For many contemporary practitioners facing patients whose disease process continues to advance despite their efforts, the experience is tantamount to encountering failure and therapeutic impotence; difficulties in meeting this challenge or seeing the intrinsic value of ministering to the dying can lead to demoralization and professional burnout.
In fact, professional caregivers experience significant stress in response to working with dying persons as well as in response to the death of particular patients. Such stress derives from various sources, including affects originating within the caregiver as a result ofprevious or current life experiences, a particular death experience with a patient or family, "death overload" from too many patients dying in a short period of time, or from too much investment in patients over too long a time (40) . An environment with unrealistic workload expectations or a lack of resources to carry out the work itself can also result in caregiver stress (40) . In general, it appears that older caregivers (that is, over age 55 years) are less likely to experience burnout than are their younger colleagues (41) (42) (43) (44) . While one study reported 22% ofhospice nurses admitting that dealing with the dying was a major stress (45) , another demonstrated that, in addition to intractable pain, psychiatric symptoms in patients and dealing with relatives were the major sources ofwork-related stress (46) . A burnout dimension of depersonalization, a non-Catholic religious affiliation, and inexperience in treating terminally ill patients were found to correlate with support for the practice ofeuthanasia or assisted suicide in a recent survey of general practitioners (47) . Similarly, a survey of physicians in Washington state reported that support for euthanasia and assisted suicide decreased in proportion to one's experience in tending to the terminally ill (48) . Thus, age and experience seem to factor into whether caregivers consider further palliative measures warranted or even valuable.
Psychiatrists can assist other clinicians with sorting through the various different ethical issues that frequently arise in the palliative care setting. For example, psychiatric evaluation of patients who request a hastened death can be invaluable. A survey ofpsychiatrists in Oregon indicated that only 6% were very confident that they could adequately assess in a single evaluation whether a psychiatric disorder was impairing the judgement of a patient requesting an assisted suicide. Their position on legalization of assisted suicide was associated with the likelihood that they would agree to evaluate patients requesting assisted suicide, with those in support most confident that they could render an assessment within a single evaluation (49) . Nevertheless, in a survey ofDutch consultation-liaison psychiatrists, conducted by members of the Netherlands Consortium ofConsultation/Liaison Psychiatry, most felt that psychiatrists' involvement in cases of requests for euthanasia should not be mandatory but that their most important role was to assess patients' decision-making capacity and to support the decision-making process (50) . Groups such as ours at the University ofManitoba have demonstrated the close association of a desire for death with depression, poorly controlled pain, and lack of social support. In our earlier work, we reported that patients who expressed a desire for death often met diagnostic criteria for major depression, frequently reported pain ofmoderate severity or greater, and indicated significantly lower social support on self-reports (51) . Besides examining brief screening strategies to assist with the task of psychiatric evaluation (52) , we have also demonstrated that hopelessness is a good clinical marker for suicidal ideation in the terminally ill (53) . More recently we reported that the "will to live" of dying patients is highly variable, with the explanation for these changes shifting as death approaches. Specifically, within the first 24 hours of admission to a palliative care unit, anxiety seemed to be the most significant predictor of "will to live" in a cohort of'hos, pitalized patients with advanced terminal cancer. The initially prominent anxiety was later replaced by depression and eventually, as death drew nearer, by more physically mediated sources ofdistress (54) . Notably, these sources ofsuffering are largely remediable, and dying indiviuals can often improve with appropriate therapeutic measures. Psychiatric interventions need to be a part ofthe larger therapeutic armamentarium within the context of excellent, comprehensive palliative care.
Psychiatric Disorders and Terminal Illness
Do not go gentle into that good night, Old age should burn and rave at close of day; Rage, rage against rhe dying of the light.
-Dylan Thomas, Do Not Go Gentle Into That Good Night
For many patients, facing a terminal prognosis is traumatic and accompanied by psychiatric disturbance. The incidence of depression, anxiety, and delirium all increase with heightened levels of physical disability and advanced illness. As disease progresses, so too does vulnerability to the development of comorbid psychiatric disorders and complications (55) (56) (57) . A recent study by Minagawa and others reported the prevalence of psychiatric disorders among 109 terminally ill cancer patients admitted to a palliative care unit (58) . In this sample, 53.7% met criteria for a specific psychiatric disorder. The most common disorders reported within this sample included delirium (28%), dementia (10.7%), adjustment disorders (7.5%), amnestic disorders (3.2%), major depression (3.2%), and generalized anxiety disorder (1.1%). Although depression and delirium may be underestimated in this sample, this study nevertheless points to the fact that psychiatric morbidity in the terminally ill is considerable.
Cancer patients with pain are twice as likely to develop psychiatric complications as are patients without pain (59) . In a sample of215 cancer patients, 39% of those who received a psychiatric diagnosis reported significant pain. In contrast, only 19% ofpatients without a psychiatric diagnosis had significant pain. In patients with pain, 69% ofthe psychiatric diagnoses were adjustment disorder with depressed or mixed emotional features, and 15% were major depression. Neuropsychiatric symptoms and syndromes clearly coexist with many other physical and psychological symptoms and impact on the quality oflife. Thus, prompt recognition and effective treatment is critical to the well-being oftenninally ill patients.
Depression at the End ofLife
All dying patients, during the course of their illness, can be expected to express sadness as part of their grieving process. Data from patients with advanced disease suggest that depression is more common in later stages of illness, ranging in prevalence from 23% to 58% (60) (61) (62) (63) . Our group at the University ofManitoba studied 2 factors that might influence the measurement and diagnosis of depression in the terminally ill; that is, the severity with which symptoms must be expressed before they are considered clinically significant and how somatic symptoms that may be caused by the medical illness are dealt with (62) . This study used different approaches of case identification to examine prevalence rates for major and minor depression in a group of 130 terminally ill cancer patients. The prevalence rates for depression were reported to be between 13% and 26.1%, with the less stringent or low-threshold diagnostic approach greatly increasing the overall prevalence of depressive disorders. The inclusion of somatic symptoms, on the other hand, appeared to be less ofa confounder than anticipated. Nevertheless, clinical wisdom and experience suggest that greater emphasis should be placed on psychological symptoms--depressed mood, loss of interest, helplessness, hopelessness, excessive guilt, feelings of worthlessness, desire for death-rather than physical symptoms. It would appear, however, that small differences between investigators in the application of symptom-severity thresholds can result in large differences in prevalence rates for depression (62) (63) (64) .
Depression continues to be underdiagnosed and undertreated in the terminally ill, further impairing their quality oflife and adding to their suffering (65, 66) . This is particularly unfortunate and unnecessary, given that simply asking dying patients about their mood has been shown to be an effective screening approach (52) . Both psychological and psychopharmacological treatments are proven effective in patients with major depression and should therefore be employed concurrently. Psychologically, patients who are terminally ill are best approached by promoting active coping strategies to maintain their level of functioning and assisting them to understand, manage, and work through their feelings related to their disease. Active coping and regaining a sense ofmastery and control can sometimes be achieved with various techniques such as relaxation, biofeedback, guided imagery, or hypnosis. Other psychodynamic approaches, which focus on the development of new psychological understanding and coping strategies, are often less practical in this patient population (17, 67) .
In terms ofpharmacotherapy, 3 controlled studies addressing the use of antidepressants in cancer patients have been published to date. Rifkin and others found trimipramine superior to placebo in alleviating symptoms of depression in patients with advanced disease (68) . In a controlled trial of cancer patients, Costa and others found that mianserin reduced the severity of depressive symptoms and improved the quality of life (69) . In a controlled study of cancer patients treated with imipramine, Evans and colleagues found significantly reduced scores on the Hamilton Depression Rating Scale as well as improved scores on a self-report adjustment-to-illness scale (70) . Although there is more experience and literature on the use of tricyclic antidepressants in terminally ill patients, selective serotonin reuptake inhibitors (SSRls), serotonin norepinephrine reuptake inhibitors (SNRls), and reversible inhibitors of monoamine oxidase A (RIMAs) are probably the most appropriate classes ofmedications because oftheir more favourable side effect profile. Psychostimulants are an alternative and effective treatment for depression in the terminally ill (71, 72) . Two controlled studies have shown methylphenidate to be more effective than placebo for treating depression in the elderly (73, 74) . Several noncontrolled studies have evaluated the use of pemoline, dextroamphetamine, and methylphenidate in cancer patients, with a response rate of 73% to 100% (75, 76) . Stimulants have the advantages of a rapid onset of action, decreased fatigue, and good tolerance, and they may even be helpful for mild cognitive impairment, improving attention and concentration (77) . Their rapid action make them especially appropriate for patients with days or a few weeks to live (78) . Successful treatment can often improve energy, appetite, and sleep, promoting a sense of well-being.
Anxiety and Terminal Illness
The issue of anxiety in the terminally ill has received only limited attention (79) . However, the available literature suggests that it may be very common in this patient population, exceeding 70% according to some studies (2, 56) . The terminally ill patient presents with a complex mixture of physical and psychological symptoms in the context of a frightening reality. Thus, recognizing anxiety symptoms that require treatment can be challenging. Patients with anxiety complain oftension or restlessness or exhibit jitteriness, autonomic hyperactivity, vigilance, insomnia, distractibility, shortness of breath, numbness, apprehension, worry, or rumination (55, 56) . Physical or somatic manifestations of anxiety often overshadow the psychological or cognitive ones and are often the presenting symptoms (80) . The consultant must use these symptoms as a cue to inquire about the patient's psychological state, which is commonly one of fear, worry, or apprehension.
While anxiety may present on the basis of an actual underlying anxiety disorder-such as panic disorder, generalized anxiety disorder, or posttraumatic stress disorder-one must consider several other possibilities, including: 1) fear ofdeath and the dying process itself; 2) spiritual or existential concerns; 3) a chronic coping or personality style, such as avoidant or dependent personality; 4) medication side effects, such as akathisia from antiemetics; 5) undertreated symptoms such as pain, dyspnea, or sepsis; 6) withdrawal states from sedatives or opiates; and 7) delirium (4). To address the issue of treatment, the source of anxiety must be explored and, to the extent possible, relieved.
Significant anxiety in dying patients often requires pharmacotherapy, in conjunction with psychological support and behavioural interventions. Pharmacotherapy primarily involves benzodiazepines, neuroleptics, antidepressants, and opioid analgesics. Short-acting benzodiazepines such as lorazepam, Vol 45, No2 alprazolam, and midazolam are effective anxiolytics, with the latter being particularly useful for rapid sedation in patients who are agitated or markedly anxious (81) . Neuroleptics such as haloperidol, thioridazine, and chlorpromazine are useful when benzodiazepines are contraindicated or prove ineffective in controlling anxiety (4, 82) . One must be cautious, however, with respect to their propensity to produce hypotension, anticholinergic and extrapyramidal side effects, and possibly neuroleptic malignant syndrome. Tricyclic antidepressants can be effective in treating anxiety that accompanies depression and panic disorder. However, their utility in the terminally ill is limited, given their relatively long latency before onset. Narcotic analgesics are particularly effective for anxiety that accompanies pain and dyspnea (83) . Psychological support can be provided using a supportive, crisis-oriented approach. Cognitive-behavioural techniques such as providing information and teaching self-monitoring, distraction, and relaxation can bolster adaptive coping. Behavioural techniques focusing on behaviour modification often use elements of muscular relaxation and positive imagery (17, 84, 85) .
Organic Mental Disorders and Terminal Illness
The presence of delirium in the final days oflife is frequently referred to in the literature as terminal restlessness or terminal agitation. The prevalence oforganic mental disorders such as delirium in cancer patients that require psychiatric consultation has been found to range from 25% to 40% to as high as 85% during the terminal stages of illness (55) . There appears to be a clear association between the severity of physical illness and the prevalence of delirium (86) . As many as onethird of the cases of delirium seen in the terminally ill are reversible (87, 88) , while others can be managed only by heavy sedation (4, 89, 90) .
Delirium can be due either to the direct effects of cancer on the central nervous system (CNS) or to indirect CNS effects of the disease or treatments: medications, electrolyte imbalance, failure of a vital organ or system, infection, vascular complications, and preexisting cognitive impairment or dementia. Narcotic analgesics are common causes of confusional states, particularly in elderly and terminally ill individuals (91) . Early symptoms ofdelirium can be misdiagnosed as anxiety, anger, depression, or psychosis. In any patient showing acute onset of agitation, impaired cognitive function, altered attention span, or a fluctuating level of consciousness, a diagnosis ofdelirium should be considered (86) .
Often when faced with a delirious dying patient, symptomatic management is all that is available. There are many reasons for this: 1) the cause of the delirium is often multifactorial or simply not identifiable; 2) the cause, even if identified, is often irreversible, such as hepatic failure or brain metastasis; 3) the work-up may be limited by virtue of the setting, as in a hospice or home; or 4) invasive diagnostic procedures may inflict more discomfort, with little potential to alter a Clinical Implications
Psychiatrists have an important role to play in the care of dying patients.
Psychiatrists can help families whose loved ones are nearing death.
Psychiatrists can assist end-of-life health care providers deal with the psychological challenges they face in providing palliative care.
Limitations
This is a qualitative literature review.
There are a limited number of intervention studies targeting psychiatric disorders in the terminally ill.
symptomatic treatment course. Optimal management often requires aggressive supportive measures such as one-on-one nursing care and pharmacotherapy. Neuroleptics are the primary treatment for delirium and include drugs such as haloperidol, chlorpromazine, thioridazine, and methotrimiprazine (4, 8) . The role ofthe newer antipsychotics is yet to be clarified, but may provide a future therapeutic option for the treatment of delirious patients with advanced illness. Benzodiazepines, either alone or in combination with neuroleptics, are often required to control the agitated delirious patient. When heavy sedation is required, the short-acting benzodiazepine midazolam-with or without opiate analgesics-ean be very effective.
Conclusions
An anonymous 16th-century author described the role of a physician as being "to cure sometimes, to relieve often,and to comfort always." At the end of the 20th century, after much preoccupation with technology and a largely cure-oriented focus, the discipline ofmedicine is once again slowly coming to recognize its part in addressing the concerns of the dying. While psychiatry has made tremendous inroads toward providing care to patients throughout the life cycle, its presence is only beginning to be felt in end-of-life care. Within the domains ofrelief and comfort, where palliative care essentially resides, psychiatry has an expanded and important role to play.
